1 We defined 156 homology groups (H-groups), which were further
2 We defined 205 independent risk-associated signals with the s
3 For this work,
we defined a chemical reaction relationship as the transforma
4 We defined a day with hypoactive delirium as a day with posit
5 Here,
we defined a four-cell-stage developmental framework for Tex
6 Using a combination of genetic and epidemiological data
we defined a malaria transmission unit as the area contributi
7 We defined a minimal Rossmann-like structural motif (RLM), id
8 In addition,
we defined a new severity category (level IV) with prolonged
9 Additionally,
we defined a specific nucleosome/nucleosome-depleted region s
10 We defined a tissue-resident MBC phenotype that was predomina
11 We defined Aft1- and Yap1-dependent transcriptional sites in
12 Using atomic coordinates of this model
we defined an energetically optimized K-PHI structure, in whi
13 We defined an index called the Quantitative Response Assessme
14 To gauge IRE1alpha function,
we defined an XBP1s-dependent gene signature, which revealed
15 e compared from the time exception points were given, which
we defined as conditional waitlist outcomes.
16 d liver macrophages into an antiinflammatory phenotype that
we defined as MarcohiHmoxhiMHC class IIlo erythrophagocytes.
17 We defined catchment areas (transplant referral regions [TRRs
18 lantation and patient-derived xenograft preclinical models,
we defined clear functions for CDK4 and CDK6 in facilitating
19 Using a reporter gene for eilA activation,
we defined conditions under which this gene was differentiall
20 Here,
we defined contributions of the Dtr protein TraK, a predicted
21 Using a combination of confocal, super-resolution and EM,
we defined DAT localization and its membrane diffusion parame
22 Further,
we defined different types of aging patterns in different ind
23 We defined endocardial-epicardial dissociation as phase diffe
24 In detail,
we defined EP300 as a panCancer inhibitor of the TIME most li
25 We defined expander states as those who expanded Medicaid on
26 We defined high rmPFC activation as a difference between stre
27 We defined HIV PrEP utilization as the number of people takin
28 We defined IDU-IE using a validated combination of ICD-9 code
29 We defined injection behavior profile by both injection frequ
30 We defined left and right frontal, parietal, and temporal are
31 We defined LO disease as >7 days of life in the perinatal mod
32 In the current study,
we defined "
M1" macrophage and "M1"/"M2" ratio by transcripto
33 We defined MACE as a composite of cardiovascular death, myoca
34 e (ERK) and JUN N-terminal kinase (JNK) signaling pathways,
we defined MAP3K19 as a novel regulator of MAPK signaling.
35 We defined maturational trajectories between the Electroencep
36 We defined mild-to-moderate iodine deficiency as a baseline m
37 onal study of adult patients undergoing noncardiac surgery,
we defined MINS as new troponin elevation within 30 days foll
38 Using this model,
we defined PIUKALL as a continuous variable that assigns pers
39 First,
we defined single-subject atrophy maps by comparing cortical
40 Within the endothelial cell population,
we defined subsets with angiogenic capacity plus clear signs
41 We defined success as >=20% IOP reduction or >=1 medication r
42 e profiling upon acute fusion protein inactivation in vivo,
we defined the core set of direct transcriptional targets of
43 We defined the minimal length of the RNA template for in vitr
44 d down the optimization to two accelerating potentials, and
we defined the optimization of these in a simple rule by acco
45 d with pseudorabies virus retrograde tracing from the iWAT,
we defined the preganglionic and postganglionic sympathetic i
46 To track disease progression across the age spectrum,
we defined the relationship between disease severity as measu
47 We defined the RM composition of innate and innate-like cell
48 We defined the transcriptome map of healthy human IVD by perf
49 Here,
we defined the transcriptome of RIS and discovered that genes
50 Here,
we defined two sets of 21 custom gene sets, called the functi